Test Details: Prolonged treatment of human cytomegalovirus (CMV) infection with ganciclovir (GCV) or its oral prodrug, valganciclovir, may result in antiviral drug resistance when viral replication is incompletely suppressed. Diagnostic mutations in the cytomegalovirus UL97 kinase gene are used to assess the level of associated ganciclovir resistance and therapeutic options.